Andrew Hessel, Genomic Futurist

Andrew Hessel is a futurist and catalyst in biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is a Distinguished Researcher with Autodesk Inc.’s Bio/Nano Programmable Matter group, based out of San Francisco. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

Trained in microbiology and genetics, Andrew has continually worked at the forefront of genomics, first to read and comprehend bacterial, human, and other genomes and more recently to write them. He believes the technology that makes this possible, called synthetic biology, is revolutionary and that it will eventually surpass information technology (IT) as an economic engine and driver of societal change. He speaks widely on topics that include cells as living computers, life science as an emerging IT industry, and biological safety and security.

Donate BTC: 1DUUZbiqjbJvzjuRZEwTS47bqgmnhEJ4XG

Donate ETH: 0x981FcEAAa895C6cee76D2876e9AfC649Dc0C4c75

More Posts:

Innovative Jaguar Concept
Automated Valet Parking System And A Space Saver
PR2 Robot Has Been Taught The Meaning Of Tactile Adjectives (+VIDEO)
Ray Kurzweil: Your Thoughts Create Your Brain
Cameras Talk To Each Other To Track Pedestrians
castAR - Share Your 3D World As It Springs To Life
Voxel8: The World's First 3D Electronics Printer
A Layered Fabric 3D Printer for Soft Interactive Objects
Smartwatches Can Now Track Your Finger In Mid-Air Using Sonar
Medical 3D Printing by Christopher Barnatt